Scientific article
English

PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke

Published in

Clinical chemistry, vol. 51, no. 11, p. 2043-2051

Publication date

2005

Abstract

Plasma markers for stroke could be useful in diagnosis and prognosis and in prediction of response of stroke patients to therapy. PARK7 and nucleoside diphosphate kinase A (NDKA) are increased in human postmortem cerebrospinal fluid (CSF), a model of global brain insult, suggesting that measurement in CSF and, more importantly, in plasma may be useful as a biomarker of stroke.

Keywords

  • Biological Markers/blood/cerebrospinal fluid
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay
  • Europe
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • NM23 Nucleoside Diphosphate Kinases
  • North America
  • Nucleoside-Diphosphate Kinase/blood/cerebrospinal fluid
  • Oncogene Proteins/blood/cerebrospinal fluid
  • Plasma
  • Proteome/analysis
  • Sensitivity and Specificity
  • Stroke/blood/cerebrospinal fluid/diagnosis

UNIGE research groups

Citation (ISO format)

ALLARD, Laure et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. In: Clinical chemistry, 2005, vol. 51, n° 11, p. 2043–2051. doi: 10.1373/clinchem.2005.053942

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0009-9147
655views
1downloads

Technical informations

Creation

15/11/2013 12:44:00

First validation

15/11/2013 12:44:00

Update

09/01/2025 17:06:31

Status update

09/01/2025 17:06:31

Last indexation

09/01/2025 17:11:10
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated